Baxter's Meridian recall gets class I label
This article was originally published in Clinica
Executive Summary
Baxter shares fell 24 cents to hit a low of $38.32 on December 13 after the FDA slapped a class I label on a recall made by the company concerning an out-of-production haemodialysis machine line.